Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Metastatic to Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05638425
What this trial is testing

Radiotherapy Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of NSCLC Patients With Symptomatic Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer MetastaticBrain Metastases
Xiangya Hospital of Central South University 20
Testing effectiveness (Phase 2)Looking for participantsNCT05554302
What this trial is testing

Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis

Who this might be right for
Brain MetastasesBrain Cancer
Baptist Health South Florida 20
Testing effectiveness (Phase 2)Ended earlyNCT02768337
What this trial is testing

Cambridge Brain Mets Trial 1

Who this might be right for
Lung CancerBreast CancerBrain Cancer+2 more
Cambridge University Hospitals NHS Foundation Trust 26
Large-scale testing (Phase 3)Study completedNCT00639366
What this trial is testing

Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
Anglo Celtic Cooperative Oncology Group 390
Not applicableUnknownNCT04626206
What this trial is testing

Multi -paramEtric Imaging to Assess Treatment REsponse After Stereotactic Radiosurgery of Brain Metastases

Who this might be right for
Brain Metastases, Adult
Royal Marsden NHS Foundation Trust 12
Not applicableActive Not RecruitingNCT03223922
What this trial is testing

Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

Who this might be right for
Brain Metastases
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 40
Testing effectiveness (Phase 2)Ended earlyNCT02684071
What this trial is testing

Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors

Who this might be right for
Recurrent Childhood MedulloblastomaRecurrent Childhood EpendymomaChildhood Atypical Teratoid/Rhabdoid Tumor+2 more
Nicklaus Children's Hospital f/k/a Miami Children's Hospital 3
Not applicableLooking for participantsNCT06933199
What this trial is testing

Neoadjuvant Stereotactic Radiotherapy for Brain Metastasis

Who this might be right for
Brain Metastases
University Hospital Ostrava 260
Not applicableUnknownNCT06483919
What this trial is testing

The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer

Who this might be right for
Small-cell Lung Cancer
Jinming Yu 228
Not applicableStudy completedNCT00003324
What this trial is testing

Radiation Therapy With or Without Surgery in Treating Patients Who Have Brain Metastases

Who this might be right for
Metastatic Cancer
Jonsson Comprehensive Cancer Center 61
Not applicableStudy completedNCT00983359
What this trial is testing

Stereotactic Radiation Therapy in Treating Patients With Brain Metastases

Who this might be right for
Metastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Ohio State University Comprehensive Cancer Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT06810804
What this trial is testing

A Phase IIa Study to Evaluate NBQ72S

Who this might be right for
Breast Cancer
Nantong Bencao Quadriga Medical Technology Co. Ltd. 10
Not applicableStudy completedNCT01603849
What this trial is testing

Prophylactic Cranial Irradiation in Patients With Lung Adenocarcinoma With High Risk of Brain Metastasis

Who this might be right for
Lung Cancer
Instituto Nacional de Cancerologia de Mexico 84
Testing effectiveness (Phase 2)Looking for participantsNCT06741085
What this trial is testing

Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain

Who this might be right for
Non Small Cell Lung Cancer Metastatic
Memorial Sloan Kettering Cancer Center 56
Testing effectiveness (Phase 2)WithdrawnNCT05567055
What this trial is testing

Central Nervous System Efficacy of Capmatinib in NSCLC With Brain Metastases With cfDNA Positive MET Alterations

Who this might be right for
Non-small Cell Lung Cancer
Timothy Burns, MD, PHD
Testing effectiveness (Phase 2)Ended earlyNCT00696943
What this trial is testing

18F ML-10 for Early Detection of Response of Brain Metastases to SRS

Who this might be right for
Metastasis to Brain of Unknown Primary
Aposense Ltd. 1
Testing effectiveness (Phase 2)Ended earlyNCT04644315
What this trial is testing

A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors

Who this might be right for
NeoplasmsColorectal NeoplasmsMelanoma+25 more
Hoffmann-La Roche 1
Not applicableStudy completedNCT00255671
What this trial is testing

Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders

Who this might be right for
Brain and Central Nervous System TumorsMetastatic CancerRadiation Toxicity
Case Comprehensive Cancer Center 76
Testing effectiveness (Phase 2)Study completedNCT00415363
What this trial is testing

Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy

Who this might be right for
Non Small Cell Lung CancerSmall Cell Lung Cancer
Eli Lilly and Company 109
Testing effectiveness (Phase 2)Ended earlyNCT03430947
What this trial is testing

Vemurafenib Plus Cobimetinib After Radiosurgery in Patients With BRAF-mutant Melanoma Brain Metastases

Who this might be right for
Malignant Melanoma Stage IVBRAF V600 MutationBrain Metastases
Technische Universität Dresden 20
Next Page